Document is current
Any future updates will be listed below
-
Authors
Uraki, Ryuta https://orcid.org/0000-0003-0890-1922
Korber, Bette
Diamond, Michael S. https://orcid.org/0000-0002-8791-3165
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
- License Information
-
More Information
Article History
Accepted: 8 October 2025
First Online: 10 November 2025
Competing interests
: Y.K. has received grant support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Shionogi, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation and Fuji Rebio. Y.K. is a co-founder of FluGen. M.S.D. is a consultant or adviser for Inbios, Moderna, IntegerBio, Merck, GlaxoSmithKline and Akagera Medicines. The laboratory of M.S.D. has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology and IntegerBio. The other authors declare no competing interests.
